Cargando…

Identification of metabolism-related long non-coding RNA (lncRNA) signature predicts prognosis and immune infiltrates in hepatocellular carcinoma

BACKGROUND: Cancer-associated metabolic reprogramming promotes cancer cell differentiation, growth, and influences the tumor immune microenvironment (TIME) to promote hepatocellular carcinoma (HCC) progression. However, the clinical significance of metabolism-related lncRNA remains largely unexplore...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xiaodong, Qian, Jing, Yao, Ninghua, Pocha, Christine, Kang, Koo Jeong, Angelico, Roberta, Zhu, Guodong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201179/ https://www.ncbi.nlm.nih.gov/pubmed/35722420 http://dx.doi.org/10.21037/atm-22-2194

Ejemplares similares

Pyroptosis-Related LncRNA Signature Predicts Prognosis and Is Associated With Immune Infiltration in Hepatocellular Carcinoma
por: Liu, Ze-Kun, et al.
Publicado: (2022)

A five lncRNA signature for prognosis prediction in hepatocellular carcinoma
por: Sun, Yongqiang, et al.
Publicado: (2019)

Development and Validation of an Immune-Related lncRNA Signature for Predicting the Prognosis of Hepatocellular Carcinoma
por: Kong, Weihao, et al.
Publicado: (2020)

Computational Identification of Immune- and Ferroptosis-Related LncRNA Signature for Prognosis of Hepatocellular Carcinoma
por: Huang, Anmin, et al.
Publicado: (2021)

Ferroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma
por: Fang, Chongkai, et al.
Publicado: (2022)

An m6A-Related lncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma
por: Zhang, Zhenyu, et al.
Publicado: (2022)

A novel Cuproptosis-related LncRNA signature to predict prognosis in hepatocellular carcinoma
por: Zhang, Genhao, et al.
Publicado: (2022)

lncRNA involvement in hepatocellular carcinoma metastasis and prognosis
por: Abbastabar, Maryam, et al.
Publicado: (2018)

LncRNA profile study reveals four-lncRNA signature associated with the prognosis of patients with anaplastic gliomas
por: Wang, Wen, et al.
Publicado: (2016)

An immune-related lncRNA signature for the prognosis of pancreatic adenocarcinoma
por: Qi, Bing, et al.
Publicado: (2021)

An Aggrephagy-Related LncRNA Signature for the Prognosis of Pancreatic Adenocarcinoma
por: Huang, Xueyuan, et al.
Publicado: (2023)

Construction of an immune-related lncRNA signature as a novel prognosis biomarker for LUAD
por: Chen, Hang, et al.
Publicado: (2021)

A novel qualitative signature based on lncRNA pairs for prognosis prediction in hepatocellular carcinoma
por: Bu, Xiaoyun, et al.
Publicado: (2022)

Cuproptosis-Related LncRNA Signature for Predicting Prognosis of Hepatocellular Carcinoma: A Comprehensive Analysis
por: Chen, Qiqi, et al.
Publicado: (2022)

A cuproptosis-related lncRNA signature for predicting prognosis and immune response in hepatocellular carcinoma
por: Wu, Jingyi, et al.
Publicado: (2023)

LncRNA profile study reveals a seven-lncRNA signature predicts the prognosis of patients with colorectal cancer
por: Huang, Rui, et al.
Publicado: (2020)

Analysing the relationship between lncRNA and protein-coding gene and the role of lncRNA as ceRNA in pulmonary fibrosis
por: Song, Xiaodong, et al.
Publicado: (2014)

An Exosome-Related Long Non-coding RNA (lncRNA)-Based Signature for Prognosis and Therapeutic Interventions in Lung Adenocarcinoma
por: Li, Jinghong, et al.
Publicado: (2023)

The effect of SNPs in lncRNA as ceRNA on the risk and prognosis of hepatocellular carcinoma
por: Mo, Han, et al.
Publicado: (2022)

Identification of a novel lncRNA prognostic signature and analysis of functional lncRNA AC115619.1 in hepatocellular carcinoma
por: Gan, Binliang, et al.
Publicado: (2023)

Innovative signature establishment using lymphangiogenesis-related lncRNA pairs to predict prognosis of hepatocellular carcinoma
por: Cao, Jincheng, et al.
Publicado: (2022)

Identification and Validation of Necroptosis-Related LncRNA Signature in Hepatocellular Carcinoma for Prognosis Estimation and Microenvironment Status
por: Chen, Cong, et al.
Publicado: (2022)

Identification of an Oxidative Stress-Related LncRNA Signature for Predicting Prognosis and Chemotherapy in Patients With Hepatocellular Carcinoma
por: Zhong, Zixuan, et al.
Publicado: (2022)

Identification and Characterization of an Ageing-Associated 13-lncRNA Signature That Predicts Prognosis and Immunotherapy in Hepatocellular Carcinoma
por: Li, Fulei, et al.
Publicado: (2023)

A novel necroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma
por: Wang, Jianguo, et al.
Publicado: (2022)

An exosome-related lncRNA signature correlates with prognosis, immune microenvironment, and therapeutic responses in hepatocellular carcinoma
por: Peng, Wang, et al.
Publicado: (2023)

Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma
por: Li, Wang, et al.
Publicado: (2020)

The prognostic value of an autophagy-related lncRNA signature in hepatocellular carcinoma
por: Yang, Shiming, et al.
Publicado: (2021)

A 7-lncRNA signature associated with the prognosis of colon adenocarcinoma
por: Fu, Xiaorui, et al.
Publicado: (2020)

An Immunity-Associated lncRNA Signature for Predicting Prognosis in Gastric Adenocarcinoma
por: Zhao, Xiaowen, et al.
Publicado: (2022)

A seven-lncRNA signature for predicting prognosis in breast carcinoma
por: Xu, Min, et al.
Publicado: (2021)

Pyroptosis-Related LncRNA Signatures Correlate With Lung Adenocarcinoma Prognosis
por: Huang, Hua, et al.
Publicado: (2022)

Identification of the 11-lncRNA signatures associated with the prognosis of endometrial carcinoma
por: Wan, Jing, et al.
Publicado: (2021)

An eight-mRNA signature outperforms the lncRNA-based signature in predicting prognosis of patients with glioblastoma
por: Gong, Zhenyu, et al.
Publicado: (2020)

Machine learning integrations develop an antigen-presenting-cells and T-Cells-Infiltration derived LncRNA signature for improving clinical outcomes in hepatocellular carcinoma
por: Wang, Xiaodong, et al.
Publicado: (2023)

Identification of a pyroptosis-related lncRNA signature in the regulation of prognosis, metabolism signals and immune infiltration in lung adenocarcinoma
por: Zhou, Shuyi, et al.
Publicado: (2022)

The development and validation of a novel senescence-related long-chain non-coding RNA (lncRNA) signature that predicts prognosis and the tumor microenvironment of patients with hepatocellular carcinoma
por: Huang, Enmin, et al.
Publicado: (2022)

An lncRNA Model for Predicting the Prognosis of Hepatocellular Carcinoma Patients and ceRNA Mechanism
por: Zhang, Hao, et al.
Publicado: (2021)

Identification and validation of an eight-lncRNA signature that predicts prognosis in patients with esophageal squamous cell carcinoma
por: Zhang, Jinfeng, et al.
Publicado: (2022)

Genomewide identification of a novel six‐LncRNA signature to improve prognosis prediction in resectable hepatocellular carcinoma
por: Wu, Ying, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lagan6e0egqa8nditvn3ufhbrc